Kanhangad Eye Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.05 Cr
as on 23-12-2024
About Kanhangad Eye Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.05 Cr.
Padincharekkara Sureshbabu and Athayi Mukesh serve as directors at the Company.
- CIN/LLPIN
U85300KL2022PTC078921
- Company No.
078921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kasargod, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kanhangad Eye Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Athayi Mukesh  | Managing Director | 18-Nov-2022 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padincharekkara Sureshbabu | Director | 18-Nov-2022 | Current |
Financial Performance of Kanhangad Eye Care.
Enhance accessibility to Kanhangad Eye Care's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kanhangad Eye Care?
Unlock access to Kanhangad Eye Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Banrays Lens & Optics Private LimitedActive 8 years 11 monthsPadincharekkara Sureshbabu and Athayi Mukesh are mutual person
- Payyannur Eye Care Private LimitedActive 2 years 3 months
Padincharekkara Sureshbabu and Athayi Mukesh are mutual person
- A K Gopalan Nethralaya & Pef Eye Institute Private LimitedActive 1 year 4 months
Athayi Mukesh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Aug 2023 | ₹3.17 M | Open |
Others Creation Date: 30 Jun 2023 | ₹7.29 M | Open |
How Many Employees Work at Kanhangad Eye Care?
Kanhangad Eye Care has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanhangad Eye Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanhangad Eye Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
